Varian Medical Systems (VAR) Tops Q1 EPS by 1c; Issues Q3 Outlook

Varian Medical Systems (NYSE: VAR) reported Q2 EPS of $1.04, $0.01 better than the analyst estimate of $1.03. Revenue for the quarter came in at $779 million versus the consensus estimate of $772.84 million.

Varian Medical Systems sees Q3 2014 EPS of $1.06-$1.10, versus the consensus of $1.03.

Varian Medical Systems sees FY2014 EPS of $4.22-$4.34, versus the consensus of $4.3.

For earnings history and earnings-related data on Varian Medical Systems (VAR) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Forgent Power Solutions jumps as Bernstein sees massive earnings upside
• Rivian reports Q3 2026 production of 19,751 vehicles